Haematological effects from Radioiodine Treatment of Thyroid Carcinoma
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 29 (8) , 1035-1039
- https://doi.org/10.3109/02841869009091796
Abstract
(1990). Haematological effects from Radioiodine Treatment of Thyroid Carcinoma. Acta Oncologica: Vol. 29, No. 8, pp. 1035-1039. doi: 10.3109/02841869009091796Keywords
This publication has 10 references indexed in Scilit:
- The long-term hazards of the treatment of thyroid cancer with radioiodineThe British Journal of Radiology, 1986
- The Development of Radiation Late Effects to the Bone Marrow after Single and Chronic ExposureInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1985
- Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experienceThe British Journal of Radiology, 1984
- The treatment of thyroid carcinoma with radioactive iodineSeminars in Nuclear Medicine, 1978
- Absorbed doses in the marrow during131I therapyThe British Journal of Radiology, 1977
- External radiotherapy and radioiodine in the treatment of 359 thyroid cancersThe British Journal of Radiology, 1975
- Induction of Leukaemia by 131I Treatment of Thyroid CarcinomaBritish Journal of Cancer, 1973
- THE METABOLIC FATE OF I131AFTER LARGE THERAPEUTIC DOSES IN PATIENTS WITH METASTATIC CARCINOMA OF THE THYROID*†Journal of Clinical Endocrinology & Metabolism, 1952
- BLOOD RADIOIODINE CONCENTRATION AND BLOOD RADIATION DOSAGE DURING I131THERAPY FOR METASTATIC THYROID CARCINOMA*Journal of Clinical Endocrinology & Metabolism, 1952
- THE TREATMENT OF METASTATIC THYROID CANCER WITH RADIOACTIVE IODINE: CREDITS AND DEBITS*†Journal of Clinical Endocrinology & Metabolism, 1949